{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T22:09:18Z","timestamp":1782425358654,"version":"3.54.5"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"48","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/17\/35\/33001"],"award-info":[{"award-number":["PG\/17\/35\/33001"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/19\/16\/34270"],"award-info":[{"award-number":["PG\/19\/16\/34270"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]},{"name":"British Heart Foundation Personal Chair","award":["CH\/13\/2\/30154"],"award-info":[{"award-number":["CH\/13\/2\/30154"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Angiotensin-converting enzyme 2 (ACE2) is the cellular entry point for severe acute respiratory syndrome coronavirus (SARS-CoV-2)\u2014the cause of coronavirus disease 2019 (COVID-19). However, the effect of renin-angiotensin system (RAS)-inhibition on ACE2 expression in human tissues of key relevance to blood pressure regulation and COVID-19 infection has not previously been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We examined how hypertension, its major metabolic co-phenotypes, and antihypertensive medications relate to ACE2 renal expression using information from up to 436 patients whose kidney transcriptomes were characterized by RNA-sequencing. We further validated some of the key observations in other human tissues and\/or a controlled experimental model. Our data reveal increasing expression of ACE2 with age in both human lungs and the kidney. We show no association between renal expression of ACE2 and either hypertension or common types of RAS inhibiting drugs. We demonstrate that renal abundance of ACE2 is positively associated with a biochemical index of kidney function and show a strong enrichment for genes responsible for kidney health and disease in ACE2 co-expression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results indicate that neither hypertension nor antihypertensive treatment is likely to alter the expression of the key entry receptor for SARS-CoV-2 in the human kidney. Our data further suggest that in the absence of SARS-CoV-2 infection, kidney ACE2 is most likely nephro-protective but the age-related increase in its expression within lungs and kidneys may be relevant to the risk of SARS-CoV-2 infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehaa794","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T11:45:08Z","timestamp":1600256708000},"page":"4580-4588","source":"Crossref","is-referenced-by-count":47,"title":["Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1442-8927","authenticated-orcid":false,"given":"Xiao","family":"Jiang","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6238-5952","authenticated-orcid":false,"given":"James M","family":"Eales","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0580-4003","authenticated-orcid":false,"given":"David","family":"Scannali","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Nazgiewicz","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9034-6595","authenticated-orcid":false,"given":"Priscilla","family":"Prestes","sequence":"additional","affiliation":[{"name":"School of Health and Life Sciences, Federation University Australia , Ballarat, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9197-602X","authenticated-orcid":false,"given":"Michelle","family":"Maier","sequence":"additional","affiliation":[{"name":"School of Health and Life Sciences, Federation University Australia , Ballarat, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Denniff","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester , Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4568-1623","authenticated-orcid":false,"given":"Xiaoguang","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushant","family":"Saluja","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-1226","authenticated-orcid":false,"given":"Eddie","family":"Cano-Gamez","sequence":"additional","affiliation":[{"name":"Department of Cellular Genetics, Wellcome Sanger Institute , Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2430-1225","authenticated-orcid":false,"given":"Wojciech","family":"Wystrychowski","sequence":"additional","affiliation":[{"name":"Department of General, Vascular and Transplant Surgery, Medical University of Silesia , Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1163-0919","authenticated-orcid":false,"given":"Monika","family":"Szulinska","sequence":"additional","affiliation":[{"name":"Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences , Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2904-5275","authenticated-orcid":false,"given":"Andrzej","family":"Antczak","sequence":"additional","affiliation":[{"name":"Department of Urology and Uro-oncology, Karol Marcinkowski University of Medical Sciences , Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Byars","sequence":"additional","affiliation":[{"name":"Centre for Systems Genomics, School of BioSciences, The University of Melbourne , Parkville, VIC, Australia"},{"name":"Department of Pathology, The University of Melbourne , Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5643-6899","authenticated-orcid":false,"given":"Damian","family":"Skrypnik","sequence":"additional","affiliation":[{"name":"Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences , Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Glyda","sequence":"additional","affiliation":[{"name":"Department of Transplantology and General Surgery Poznan, Collegium Medicum, Nicolaus Copernicus University , Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kr\u00f3l","sequence":"additional","affiliation":[{"name":"Department of General, Vascular and Transplant Surgery, Medical University of Silesia , Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0661-8157","authenticated-orcid":false,"given":"Joanna","family":"Zywiec","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Diabetology and Nephrology, Medical University of Silesia , Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Zukowska-Szczechowska","sequence":"additional","affiliation":[{"name":"Department of Health Care, Silesian Medical College , Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1863-7539","authenticated-orcid":false,"given":"Louise M","family":"Burrell","sequence":"additional","affiliation":[{"name":"Department of Medicine and Cardiology, University of Melbourne, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5541-1358","authenticated-orcid":false,"given":"Adrian S","family":"Woolf","sequence":"additional","affiliation":[{"name":"Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, UK"},{"name":"Royal Manchester Children\u2019s Hospital and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Greenstein","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, UK"},{"name":"Division of Medicine and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-1624","authenticated-orcid":false,"given":"Pawel","family":"Bogdanski","sequence":"additional","affiliation":[{"name":"Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences , Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9573-0812","authenticated-orcid":false,"given":"Bernard","family":"Keavney","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, UK"},{"name":"Division of Medicine and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P","family":"Morris","sequence":"additional","affiliation":[{"name":"Division of Musculoskeletal & Dermatological Sciences, Faculty of Medicine, Biology and Health, University of Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Heagerty","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, UK"},{"name":"Division of Medicine and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Williams","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University College London , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B","family":"Harrap","sequence":"additional","affiliation":[{"name":"Department of Physiology, University of Melbourne , Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6955-9529","authenticated-orcid":false,"given":"Gosia","family":"Trynka","sequence":"additional","affiliation":[{"name":"Department of Cellular Genetics, Wellcome Sanger Institute , Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh J","family":"Samani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester , Leicester, UK"},{"name":"Leicester Biomedical Research Centre, National Institute for Health Research , Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5355-5910","authenticated-orcid":false,"given":"Tomasz J","family":"Guzik","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow , Glasgow, UK"},{"name":"Department of Internal and Agricultural Medicine, Jagiellonian University College of Medicine , Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6164-9941","authenticated-orcid":false,"given":"Fadi J","family":"Charchar","sequence":"additional","affiliation":[{"name":"School of Health and Life Sciences, Federation University Australia , Ballarat, VIC, Australia"},{"name":"Department of Cardiovascular Sciences, University of Leicester , Leicester, UK"},{"name":"Department of Physiology, University of Melbourne , Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8215-6567","authenticated-orcid":false,"given":"Maciej","family":"Tomaszewski","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, UK"},{"name":"Division of Medicine and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust Manchester , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"2022102511541111200_ehaa794-B1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"2022102511541111200_ehaa794-B2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"2022102511541111200_ehaa794-B3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0895-7061(99)00103-X","article-title":"The renin-angiotensin-aldosterone system: a specific target for hypertension management","volume":"12","author":"Weir","year":"1999","journal-title":"Am J Hypertens"},{"key":"2022102511541111200_ehaa794-B4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/01.RES.0000205761.22353.5f","article-title":"Angiotensin-converting enzyme II in the heart and the kidney","volume":"98","author":"Danilczyk","year":"2006","journal-title":"Circ Res"},{"key":"2022102511541111200_ehaa794-B5","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"2022102511541111200_ehaa794-B6","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102511541111200_ehaa794-B7","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2022102511541111200_ehaa794-B8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/ehjcvp\/pvaa030","article-title":"Might renin-angiotensin system blockers play a role in the COVID-19 pandemic?","volume":"6","author":"Battistoni","year":"2020","journal-title":"Eur Hear J Cardiovasc Pharmacother"},{"key":"2022102511541111200_ehaa794-B9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/CS20120162","article-title":"Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions","volume":"123","author":"Burchill","year":"2012","journal-title":"Clin Sci"},{"key":"2022102511541111200_ehaa794-B10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/expphysiol.2011.063156","article-title":"Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition","volume":"97","author":"Burrell","year":"2012","journal-title":"Exp Physiol"},{"key":"2022102511541111200_ehaa794-B11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jcmg.2019.09.005","article-title":"Plasma ACE2 activity predicts mortality in aortic stenosis and is associated with severe myocardial fibrosis","volume":"13","author":"Ramchand","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022102511541111200_ehaa794-B12","doi-asserted-by":"crossref","first-page":"e0198144","DOI":"10.1371\/journal.pone.0198144","article-title":"Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease","volume":"13","author":"Ramchand","year":"2018","journal-title":"PLoS One"},{"key":"2022102511541111200_ehaa794-B13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"2022102511541111200_ehaa794-B14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000507305","article-title":"Should COVID-19 concern nephrologists? why and to what extent? The emerging impasse of angiotensin blockade","volume":"144","author":"Perico","year":"2020","journal-title":"Nephron"},{"key":"2022102511541111200_ehaa794-B15","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1093\/cvr\/cvaa096","article-title":"Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications","volume":"116","author":"Murray","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2022102511541111200_ehaa794-B16","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s00134-020-06026-1","article-title":"Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis","volume":"46","author":"Pan","year":"2020","journal-title":"Intensive Care Med"},{"key":"2022102511541111200_ehaa794-B17","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMc2011400","article-title":"Multiorgan and renal tropism of SARS-CoV-2","volume":"383","author":"Puelles","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102511541111200_ehaa794-B18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2119\/molmed.2015.00096","article-title":"Signatures of miR-181a on the renal transcriptome and blood pressure","volume":"21","author":"Marques","year":"2015","journal-title":"Mol Med"},{"key":"2022102511541111200_ehaa794-B19","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1681\/ASN.2014121211","article-title":"Renal mechanisms of association between fibroblast growth factor 1 and blood pressure","volume":"26","author":"Tomaszewski","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2022102511541111200_ehaa794-B20","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1038\/s41467-018-07260-4","article-title":"Molecular insights into genome-wide association studies of chronic kidney disease-defining traits","volume":"9","author":"Xu","year":"2018","journal-title":"Nat Commun"},{"key":"2022102511541111200_ehaa794-B21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.kint.2018.10.029","article-title":"Uncovering genetic mechanisms of kidney aging through transcriptomics, genomics, and epigenomics","volume":"95","author":"Rowland","year":"2019","journal-title":"Kidney Int"},{"key":"2022102511541111200_ehaa794-B22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41467-018-07867-7","article-title":"Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies","volume":"10","author":"Morris","year":"2019","journal-title":"Nat Commun"},{"key":"2022102511541111200_ehaa794-B23","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The SVA package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"2022102511541111200_ehaa794-B24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ebiom.2017.09.014","article-title":"Human kidney tubule-specific gene expression based dissection of chronic kidney disease traits","volume":"24","author":"Beckerman","year":"2017","journal-title":"EBioMedicine"},{"key":"2022102511541111200_ehaa794-B25","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41588-018-0154-4","article-title":"Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation","volume":"50","author":"Gamazon","year":"2018","journal-title":"Nat Genet"},{"key":"2022102511541111200_ehaa794-B26","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1126\/science.aat1699","article-title":"Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors","volume":"361","author":"Young","year":"2018","journal-title":"Science"},{"key":"2022102511541111200_ehaa794-B27","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/en.2006-1287","article-title":"Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio","volume":"148","author":"Wakahara","year":"2007","journal-title":"Endocrinology"},{"key":"2022102511541111200_ehaa794-B28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature24265","article-title":"Landscape of X chromosome inactivation across human tissues","volume":"550","author":"Tukiainen","year":"2017","journal-title":"Nature"},{"key":"2022102511541111200_ehaa794-B29","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"2022102511541111200_ehaa794-B30","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(20)31131-4","article-title":"Hypertension, renin\u2013angiotensin\u2013aldosterone system inhibition, and COVID-19","volume":"395","author":"Williams","year":"2020","journal-title":"Lancet"},{"key":"2022102511541111200_ehaa794-B31","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1681\/ASN.2020040432","article-title":"Ultrastructural evidence for direct renal infection with SARS-CoV-2","volume":"31","author":"Farkash","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2022102511541111200_ehaa794-B32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int"},{"key":"2022102511541111200_ehaa794-B33","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1681\/ASN.2020040419","article-title":"Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology","volume":"31","author":"Batlle","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2022102511541111200_ehaa794-B34","first-page":"316","article-title":"SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2","volume":"16","author":"Allison","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2022102511541111200_ehaa794-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/307315","article-title":"Angiotensin-converting enzyme 2: the first decade","volume":"2012","author":"Clarke","year":"2012","journal-title":"Int J Hypertens"},{"key":"2022102511541111200_ehaa794-B36","doi-asserted-by":"crossref","first-page":"H1080","DOI":"10.1152\/ajpheart.00215.2020","article-title":"Letter to the editor: angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications","volume":"318","author":"Abassi","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022102511541111200_ehaa794-B37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.06.003","article-title":"Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters","volume":"128","author":"Kuba","year":"2010","journal-title":"Pharmacol Ther"},{"key":"2022102511541111200_ehaa794-B38","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1096\/fj.08-107300","article-title":"A protein complex in the brush-border membrane explains a Hartnup disorder allele","volume":"22","author":"Kowalczuk","year":"2008","journal-title":"FASEB J"},{"key":"2022102511541111200_ehaa794-B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/256294","article-title":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease","volume":"2012","author":"Tikellis","year":"2012","journal-title":"Int J Pept"},{"key":"2022102511541111200_ehaa794-B40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCULATIONAHA.120.047915","article-title":"Differentiating COVID-19 pneumonia from acute respiratory distress syndrome and high altitude pulmonary edema: therapeutic implications","volume":"142","author":"Archer","year":"2020","journal-title":"Circulation"},{"key":"2022102511541111200_ehaa794-B41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","article-title":"Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease","volume":"89","author":"Nielsen","year":"2016","journal-title":"Kidney Int"},{"key":"2022102511541111200_ehaa794-B42","doi-asserted-by":"crossref","first-page":"25196","DOI":"10.1073\/pnas.1909573116","article-title":"Galnt11 regulates kidney function by glycosylating the endocytosis receptor megalin to modulate ligand binding","volume":"116","author":"Tian","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022102511541111200_ehaa794-B43","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/ki.2008.497","article-title":"Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease","volume":"74","author":"Reich","year":"2008","journal-title":"Kidney Int"},{"key":"2022102511541111200_ehaa794-B44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fphys.2014.00227","article-title":"From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension","volume":"5","author":"Patel","year":"2014","journal-title":"Front Physiol"},{"key":"2022102511541111200_ehaa794-B45","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2020.8707","article-title":"Nasal gene expression of angiotensin-converting enzyme 2 in children and adults","volume":"323","author":"Bunyavanich","year":"2020","journal-title":"JAMA"},{"key":"2022102511541111200_ehaa794-B46","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102511541111200_ehaa794-B47","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"2022102511541111200_ehaa794-B48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41581-020-0279-4","article-title":"Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic","volume":"16","author":"South","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2022102511541111200_ehaa794-B49","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","volume":"116","author":"Guzik","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2022102511541111200_ehaa794-B50","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an Angiotensin II type I receptor-dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"key":"2022102511541111200_ehaa794-B51","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"2022102511541111200_ehaa794-B52","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/jcmm.12573","article-title":"Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats","volume":"19","author":"Klimas","year":"2015","journal-title":"J Cell Mol Med"},{"key":"2022102511541111200_ehaa794-B53","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/eurheartj\/ehaa373","article-title":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors","volume":"41","author":"Sama","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102511541111200_ehaa794-B54","first-page":"1280","article-title":"Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling","volume":"19","author":"Walters","year":"2017","journal-title":"Europace"},{"key":"2022102511541111200_ehaa794-B55","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/ndt\/gft038","article-title":"Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease","volume":"28","author":"Roberts","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2022102511541111200_ehaa794-B56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"2022102511541111200_ehaa794-B57","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/ki.2011.381","article-title":"Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy","volume":"81","author":"Batlle","year":"2012","journal-title":"Kidney Int"},{"key":"2022102511541111200_ehaa794-B58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/M20-1515","article-title":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults","volume":"173","author":"Mackey","year":"2020","journal-title":"Ann Intern Med"},{"key":"2022102511541111200_ehaa794-B59","article-title":"Position statement of the ESC council on hypertension on ACE-inhibitors and angiotensin receptor blockers","author":"Simone","year":"2020","journal-title":"Eur Soc Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/48\/4580\/46620897\/ehaa794.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/48\/4580\/46620897\/ehaa794.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T07:55:28Z","timestamp":1666684528000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/41\/48\/4580\/5940440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":59,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2020,10,27]]},"published-print":{"date-parts":[[2020,12,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaa794","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.19.20106781","asserted-by":"object"}]},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,21]]},"published":{"date-parts":[[2020,10,27]]}}}